BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29195547)

  • 1. The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.
    Gold MR; Yu Y; Wold N; Day JD
    Heart Rhythm; 2017 Dec; 14(12):1748-1755. PubMed ID: 29195547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.
    D'Onofrio A; Botto G; Mantica M; LA Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Bianchi V; Gelmini GP; Valsecchi S; Ciardiello C
    J Cardiovasc Electrophysiol; 2014 May; 25(5):500-506. PubMed ID: 24494797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Larger interventricular conduction time enhances mechanical response to resynchronization therapy.
    Padeletti L; Pieragnoli P; Ricciardi G; Perrotta L; Perini AP; Grifoni G; Ricceri I; Padeletti M; Lionetti V; Valsecchi S
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):416-23. PubMed ID: 23305325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of measures of ventricular delay on cardiac resynchronization therapy response.
    Field ME; Yu N; Wold N; Gold MR
    Heart Rhythm; 2020 Apr; 17(4):615-620. PubMed ID: 31765805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy.
    Vanderheyden M; De Backer T; Rivero-Ayerza M; Geelen P; Bartunek J; Verstreken S; De Zutter M; Goethals M
    Heart Rhythm; 2005 Oct; 2(10):1066-72. PubMed ID: 16188583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study.
    Burns KV; Gage RM; Curtin AE; Gorcsan J; Bank AJ
    Eur J Heart Fail; 2017 Oct; 19(10):1335-1343. PubMed ID: 28653458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interventricular activation delay with clinical outcomes in cardiac resynchronization therapy.
    Haqqani HM; Burri H; Kayser T; Carter N; Gold MR
    Heart Rhythm; 2023 Mar; 20(3):385-392. PubMed ID: 36436813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximization of interventricular conduction time by means of quadripolar leads for cardiac resynchronization therapy.
    Stabile G; Bianchi V; Solimene F; Iuliano A; Parisi Q; Pepi P; Bocchiardo M; Urraro F; De Simone A; Ospizio R; D'Onofrio A
    J Interv Card Electrophysiol; 2017 Oct; 50(1):111-115. PubMed ID: 28798987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
    Zanon F; Marcantoni L; Baracca E; Pastore G; Lanza D; Fraccaro C; Picariello C; Conte L; Aggio S; Roncon L; Pacetta D; Badie N; Noventa F; Prinzen FW
    Heart Rhythm; 2016 Aug; 13(8):1644-51. PubMed ID: 27450156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.
    Gold MR; Yu Y; Singh JP; Birgersdotter-Green U; Stein KM; Wold N; Meyer TE; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006055. PubMed ID: 30354310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
    Birnie D; Lemke B; Aonuma K; Krum H; Lee KL; Gasparini M; Starling RC; Milasinovic G; Gorcsan J; Houmsse M; Abeyratne A; Sambelashvili A; Martin DO
    Heart Rhythm; 2013 Sep; 10(9):1368-74. PubMed ID: 23851059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time Course of Electrical Remodeling of Native Conduction After Cardiac Resynchronization Therapy and Its Impact on Clinical Outcome.
    Cvijić M; Žižek D; Antolič B; Zupan I
    J Card Fail; 2017 Mar; 23(3):257-261. PubMed ID: 27989870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy.
    Kristiansen HM; Hovstad T; Vollan G; Keilegavlen H; Faerestrand S
    Europace; 2012 Jul; 14(7):986-93. PubMed ID: 22308084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of coronary sinus lead placement targeted to the longest right-to-left delay in patients undergoing cardiac resynchronization therapy: The Optimal Pacing SITE 2 (OPSITE 2) acute study and protocol.
    Oddone D; Solari D; Nangah R; Arena G; Mureddu R; Giorgi D; Sitta N; Bottoni N; Senatore G; Giaccardi M; Giammaria M; Themistoclakis S; Laffi M; Cipolla E; Di Lorenzo F; Carpi R; Brignole M
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1350-1357. PubMed ID: 29023821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.
    Singh JP; Fan D; Heist EK; Alabiad CR; Taub C; Reddy V; Mansour M; Picard MH; Ruskin JN; Mela T
    Heart Rhythm; 2006 Nov; 3(11):1285-92. PubMed ID: 17074633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V
    Bordachar P; Gras D; Clementy N; Defaye P; Mondoly P; Boveda S; Anselme F; Klug D; Piot O; Sadoul N; Babuty D; Leclercq C
    Heart Rhythm; 2018 Jun; 15(6):870-876. PubMed ID: 29288035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.